Mid-Aortic Syndrome: A Rare Cause of Renovascular Hypertension in Childhood Treated Percutaneously with an Unusual Vascular Access.


Journal

Current pediatric reviews
ISSN: 1875-6336
Titre abrégé: Curr Pediatr Rev
Pays: United Arab Emirates
ID NLM: 101240290

Informations de publication

Date de publication:
2020
Historique:
received: 16 03 2020
revised: 26 04 2020
accepted: 26 05 2020
pubmed: 10 6 2020
medline: 26 10 2021
entrez: 10 6 2020
Statut: ppublish

Résumé

Mid-Aortic Syndrome (MAS) is a rare vascular malformation characterized by segmental narrowing of the abdominal aorta and stenosis of its principal branches. Patients affected by MAS typically present malignant renovascular hypertension, with variable clinical symptoms like claudication, abdominal angina, and headache. Moreover, they can develop other complications, such as hypertensive encephalopathy, congestive heart failure and vascular brain accidents. Hypertension with MAS is often resistant to multidrug therapy, requiring a surgical approach to treat the clinical symptoms, prevent or block organ damage and normalize the blood pressure. Here, the case of a 4-year-old boy showing elevated blood pressure with left ventricular hypertrophy leading to idiopathic MAS, who was successfully treated with percutaneous transcatheter renal angioplasty (PTRA) using an unusual, anterograde access, is reported. In children and adolescents, vascular malformations like MAS must be considered as a possible cause of hypertension. PTRA is a successful therapeutic strategy in children with severe renovascular hypertension. Anterograde access, using an axillary artery, can be a valid approach for PTRA when femoral access is difficult to achieve.

Identifiants

pubmed: 32516103
pii: CPR-EPUB-107223
doi: 10.2174/1573396316666200609170003
doi:

Substances chimiques

Leprostatic Agents 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

320-324

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Emma Diletta Stea (ED)

Pediatric Nephrology and Dialysis Unit, Azienda Ospedaliero Universitaria Policlinico, Pediatric Hospital Giovanni XXIII, Bari, Italy.

Giovanni Meliota (G)

Azienda Ospedaliero Universitaria Policlinico, Pediatric Hospital Giovanni XXIII, Pediatric Cardiology, Bari, Italy.

Vincenza Carbone (V)

Pediatric Nephrology and Dialysis Unit, Azienda Ospedaliero Universitaria Policlinico, Pediatric Hospital Giovanni XXIII, Bari, Italy.

Diletta Torres (D)

Pediatric Nephrology and Dialysis Unit, Azienda Ospedaliero Universitaria Policlinico, Pediatric Hospital Giovanni XXIII, Bari, Italy.

Luisa Santangelo (L)

Pediatric Nephrology and Dialysis Unit, Azienda Ospedaliero Universitaria Policlinico, Pediatric Hospital Giovanni XXIII, Bari, Italy.

Giovanni Piscopo (G)

Pediatric Nephrology and Dialysis Unit, Azienda Ospedaliero Universitaria Policlinico, Pediatric Hospital Giovanni XXIII, Bari, Italy.

Paolo Giordano (P)

Post Graduated School of Pediatrics, University of Genoa, Genova, Italy.

Giuseppina Annicchiarico (G)

Regional Coordination for Rare Diseases, Regional Health Agency, Bari, Italy.

Ugo Vairo (U)

Azienda Ospedaliero Universitaria Policlinico, Pediatric Hospital Giovanni XXIII, Pediatric Cardiology, Bari, Italy.

Mario Giordano (M)

Pediatric Nephrology and Dialysis Unit, Azienda Ospedaliero Universitaria Policlinico, Pediatric Hospital Giovanni XXIII, Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH